147 related articles for article (PubMed ID: 378369)
1. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Davis HL; Davis TE
Cancer Treat Rep; 1979 May; 63(5):809-15. PubMed ID: 378369
[No Abstract] [Full Text] [Related]
2. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
3. Adriamycin and other anthracycline antibiotics under study in the United States.
Benjamin RS
Recent Results Cancer Res; 1978; 63():230-40. PubMed ID: 360330
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of malignant lymphoma with adriamycin.
Gottlieb JA; Gutterman JU; McCredie KB; Rodriguez V; Frei E
Cancer Res; 1973 Nov; 33(11):3024-8. PubMed ID: 4748450
[No Abstract] [Full Text] [Related]
5. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
Wiernik PH
Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
[No Abstract] [Full Text] [Related]
6. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Trouet A; Sokal G
Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
[TBL] [Abstract][Full Text] [Related]
7. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
[No Abstract] [Full Text] [Related]
8. [Initial results of a combined adriamycin, solcoseryl (actihaemyl) and vincristine therapy].
Baumgartner G; Waldner R; Weiss W
Wien Med Wochenschr; 1975 Feb; 125(6):96-103. PubMed ID: 1124581
[No Abstract] [Full Text] [Related]
9. [Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms].
Bile G; De Biasi R
Haematologica; 1969; 54(8):523-34. PubMed ID: 4986885
[No Abstract] [Full Text] [Related]
10. Daunorubicin treatment of adult solid tumors.
Weiss RB; Bruno S
Cancer Treat Rep; 1981; 65 Suppl 4():25-8. PubMed ID: 7049378
[No Abstract] [Full Text] [Related]
11. [Results obtained with the clinical use of adriamycin].
Esposito S; Taylor LA
Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
[No Abstract] [Full Text] [Related]
12. Adriamycin-a review.
Carter SK
J Natl Cancer Inst; 1975 Dec; 55(6):1265-74. PubMed ID: 1107570
[No Abstract] [Full Text] [Related]
13. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.
Bodey GP; Coltman CA; Hewlett JS; Freireich EJ
Arch Intern Med; 1976 Dec; 136(12):1383-8. PubMed ID: 1069570
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
[TBL] [Abstract][Full Text] [Related]
15. Adriamycin--friend and foe.
Carter SK
Am J Surg Pathol; 1977 Mar; 1(1):75-7. PubMed ID: 272124
[No Abstract] [Full Text] [Related]
16. Corticosteroid drugs: their role in oncological practice.
Lowenthal RM; Jestrimski KW
Med J Aust; 1986 Jan; 144(2):81-5. PubMed ID: 2417096
[No Abstract] [Full Text] [Related]
17. Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
Massimo L; Fossati-Guglielmoni A; Fortuna E
Helv Paediatr Acta; 1968 Aug; 23(4):315-33. PubMed ID: 4300437
[No Abstract] [Full Text] [Related]
18. [Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)].
Chauvergne J; Cappelaere P; Carton M; Gary-Bobo J; Klein T
Bull Cancer; 1978; 65(1):19-24. PubMed ID: 667371
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
20. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
